The Valley Desk

ReviewCNS drugsPublished

The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
CNS drugs
Published
Subject terms
B-Lymphocytes; Animals; Humans; Multiple Sclerosis; Antigens, CD20; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity
PubMed ID
40180777
PubMed Central ID
PMC12058931
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal